Blood test may spot pancreatic cancer without needle biopsy

NCT ID NCT02072616

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a blood test that detects circulating tumor cells (CTCs) could diagnose pancreatic cancer. Researchers planned to compare the blood test results with standard tissue biopsies in 101 people with pancreatic tumors. The trial was terminated early, so the full potential of this approach remains unclear.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could offer a less invasive way to diagnose pancreatic cancer, potentially reducing the need for risky biopsies.

What could go wrong

The trial was terminated early, so results are limited. The approach is still experimental and not yet proven to replace standard diagnostic methods.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Neoplastic Cells, Circulating pancreatic adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UH Rouen

    Rouen, 76031, France